Western Europe Medical Cannabis Market, by Route of Administration

Growth Outlook

• The Western Europe Medical Cannabis Market, by Route of Administration market is on a steady long-term growth path. Segment value stands at roughly USD 4828 Mn in 2026 and is projected to reach USD 6097 Mn by 2027 — a gain of about 26% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Inhalation leads, holding roughly 58% of segment value — the single largest regional share. Oral is the second-largest contributor. Topical make up the remainder, in descending order.
• By 2027, Inhalation alone is expected to reach USD 3564 Mn, with Oral at USD 1680 Mn.

Market Dynamics

Western Europe has emerged as a promising marketplace for medical cannabis, as governments and healthcare professionals continue to recognize the potential benefits of the drug for various medical conditions. The legalization and acceptance of cannabis for medical purposes in several countries across the region has opened up new opportunities for the market and has led to a surge in demand for the drug.

One of the key factors driving the demand for medical cannabis in Western Europe is its various routes of administration. Unlike traditional medication, medical cannabis can be consumed in multiple ways, giving patients and healthcare professionals the flexibility to choose the route of administration that best suits their needs. Let's take a closer look at some of the most popular routes of administration for medical cannabis in Western Europe.

Inhalation is one of the most common methods of administration for medical cannabis in Western Europe. This method involves smoking or vaporizing the drug, which allows for quick absorption into the bloodstream. Inhalation is preferred by many patients, as it provides fast relief from symptoms, especially in the case of acute conditions like pain or anxiety. Additionally, this method also allows for more precise dosing, as patients can control the amount and frequency of inhalation.

Oral consumption is another popular route of administration for medical cannabis in Western Europe. This can include consuming cannabis-infused edibles, capsules, or tinctures, which are absorbed through the digestive system. This method is preferred by patients who do not want to inhale the drug, and it also allows for longer-lasting effects. However, the onset of effects may be slower with oral consumption, as the drug has to be digested first.

Topical administration is also gaining popularity in Western Europe for medical cannabis. This involves applying cannabis-infused products, such as creams, lotions, or patches, directly to the skin to target local pain or inflammation. This method is especially useful for patients with skin conditions like eczema or psoriasis, as well as those with joint or muscle pain.

In conclusion, the demand for medical cannabis in Western Europe is strongly driven by its various routes of administration. With options like inhalation, oral consumption, and topical administration, patients and healthcare professionals have more choices for delivering the drug's therapeutic benefits. As the medical cannabis market in the region continues to grow, we can expect to see further advancements and innovations in these routes of administration to meet the diverse needs of patients.